Sphingosine can pre‐ and post‐condition heart and utilizes a different mechanism from sphingosine 1‐phosphate

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of biochemical and molecular toxicology

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/jbt.20227PMID 18418901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.

  2007cited by this paper
• Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.

  2007cited by this paper
• Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia.

  2007influential reference
• Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.

  2007cited by this paper
• Postconditioning: reduction of reperfusion-induced injury.

  2006cited by this paper
• High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor

  2006cited by this paper
• A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death.

  2006cited by this paper
• Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury.

  2006influential reference
• Sphingosine 1-Phosphate Analogs as Receptor Antagonists*

  2005influential reference
• The activation of Akt/PKB signaling pathway and cell survival

  2005cited by this paper
• Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert.

  2004cited by this paper
• Myocardial apoptosis and ischemic preconditioning.

  2002cited by this paper
• Sphingosine in apoptosis signaling.

  2002cited by this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKCε knockout mouse hearts

  2002cited by this paper
• Losing heart: the role of apoptosis in heart disease—a novel therapeutic target?

  2002cited by this paper
• Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection.

  2002cited by this paper
• Sphingosine‐1‐phosphate: dual messenger functions

  2002cited by this paper
• Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.

  2002cited by this paper
• The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes.

  2001cited by this paper
• Role of AKT kinase in sphingosine‐induced apoptosis in human hepatoma cells

  2001cited by this paper
• Modes of myocardial cell injury and cell death in ischemic heart disease.

  1998cited by this paper
• Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options.

  1997cited by this paper
• Myocardial reperfusion injury: experimental evidence and clinical relevance.

  1996cited by this paper
• Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

  1996cited by this paper
• Myocardial reperfusion injury: experimental evidence and clinical relevance.

  1995cited by this paper
• Sphingosine is endogenous to cardiac and skeletal muscle.

  1993cited by this paper
• Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode.

  1990cited by this paper
• Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features.

  1990cited by this paper
• Sphingolipid Mediators in Cardiovascular Cell Biology and Pathology

  year unknowncited by this paper

• Promotion of Cardiovascular Homeostasis by the Perivascular Adipose Tissue Secretome

  2025cites this paper
• The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory Support

  2025cites this paper
• A Near‐Infrared Fluorogenic Probe for Rapid, Specific, and Ultrasensitive Detection of Sphingosine in Living Cells and In Vivo

  2023cites this paper
• Sphingolipid metabolism and signaling in cardiovascular diseases

  2022cites this paper
• Ceramides and other sphingolipids as drivers of cardiovascular disease

  2021cites this paper
• The noncanonical chronicles: Emerging roles of sphingolipid structural variants.

  2020cites this paper
• Sphingolipids in the Heart: From Cradle to Grave

  2020cites this paper
• FTY720 (Fingolimod) Ameliorates Brain Injury through Multiple Mechanisms and is a Strong Candidate for Stroke Treatment

  2019cites this paper
• Ageing, sex, and cardioprotection

  2019cites this paper
• The Role of Sphingolipids in Cardiovascular Pathologies

  2018cites this paper
• High density lipoprotein / sphingosine-1-phosphate-induced cardioprotection : Role of STAT 3 as part of the SAFE pathway

  2017cites this paper
• Effect of hypoxia on the cardiovascular sphingolipid system

  2017cites this paper
• PLCε mediated sustained signaling pathways.

  2015cites this paper
• Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.

  2015cites this paper
• Effect of atrial pacing on the level of bioactive sphingolipids in the heart ventricles of the rat.

  2015cites this paper
• Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury

  2015cites this paper
• Activation of S1P1 Receptor Regulates PI3K/Akt/FoxO3a Pathway in Response to Oxidative Stress in PC12 Cells

  2015cites this paper
• Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3

  2014cites this paper
• Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning

  2014cites this paper
• The Relationship between Pre-Infarction Angina and Serum Sphingosine-1-Phosphate Levels.

  2014cites this paper
• Dose-dependent effect of aspirin on the level of sphingolipids in human blood.

  2013cites this paper
• Mechanisms and Models for Elucidating the Cardiac Effects of Sphingosine 1‐Phosphate (S1P)

  2013cites this paper
• Sphingosine-1-Phosphate and Fingolimod (FTY720) Regulate ICl,swell In HL-1 Cardiac Myocytes via Intracellular Binding And Mitochondrial ROS Production

  2013cites this paper
• Mitochondria from Oxidative Stress in the Heart PLC{varepsilon}, PKD1, and SSH1L Transduce RhoA Signaling to Protect

  2013cites this paper
• Lysophospholipid receptor activation of RhoA and lipid signaling pathways.

  2013cites this paper
• Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.

  2013cites this paper
• FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning

  2013cites this paper
• Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progress.

  2013cites this paper
• PLCε, PKD1, and SSH1L Transduce RhoA Signaling to Protect Mitochondria from Oxidative Stress in the Heart

  2013cites this paper
• © 2012 Landes Bioscience. Do not distribute. High density lipoprotein/sphingosine-1- phosphate-induced cardioprotection Role of STAT3 as part of the SAFE pathway

  2012cites this paper
• High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection

  2012cites this paper
• Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat

  2012cites this paper
• Role of the SAFE pathway and the mitochondria in HDL cholesterol (and its constituent sphingosine-1-phosphate) induced cardioprotection

  2011cites this paper
• Heart sphingolipids in health and disease.

  2011cites this paper
• P 2 X 7 receptor agonists pre-and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1 / P 2 X 7 channels

  2011cites this paper
• Ischemic preconditioning requires opening of pannexin-1/P2X7 channels not only during preconditioning but again after index ischemia at full reperfusion

  2011cites this paper
• Protective effects of adenosine in rabbit sinoatrial node ischemia–reperfusion model in vivo: control of arrhythmia by hyperpolarization-activated cyclic nucleotide-gated (HCN)4 channels

  2011cites this paper
• Effect of Apelin-Apelin Receptor System in Postischaemic Myocardial Protection: A Pharmacological Postconditioning Tool?

  2011cites this paper
• Reperfusion Injury Salvage Kinase and Survivor Activating Factor Enhancement Prosurvival Signaling Pathways in Ischemic Postconditioning: Two Sides of the Same Coin

  2011cites this paper
• Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia.

  2011cites this paper
• P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.

  2011cites this paper
• Cardioprotective role of sphingosine-1-phosphate.

  2011cites this paper
• Cardioprotective role of signal transducer activator of transcription 3 (STAT-3) against ischaemai reperfusion injuries

  2011cites this paper
• FTY 720 prevents ischemia / reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak 1 / Akt signaling

  2011cites this paper
• FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling.

  2010cites this paper
• Pannexin-I/P2X 7 Purinergic Receptor Channels Mediate the Release of Cardioprotectants Induced by Ischemic Pre- and Postconditioning

  2010cites this paper
• Ethanolamine is a novel STAT-3 dependent cardioprotective agent

  2010cites this paper
• Sphingosine Kinase and Sphingosine 1-Phosphate in Cardioprotection

  2009cites this paper
• Targeting sphingosine-1-phosphate signalling for cardioprotection.

  2009cites this paper
• Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?

  2009cites this paper
• Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

  2009cites this paper
• Sphingosine protects aging hearts from ischemia/reperfusion injury

  2009cites this paper
• Étude des propriétés et de l'impact fonctionnel de canaux potassiques dans les fibroblastes cardiaques

  2009cites this paper
• Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.

  2009influential citation
• Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia.

  2008cites this paper
• Sphingosine kinase regulation and cardioprotection.

  2008cites this paper
• Advances in Biological Regulation

  year unknowncites this paper